
Molecule: INFLIXIMAB
ChEMBL ID: CHEMBL1201581
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 1998

Molecule: CERTOLIZUMAB PEGOL
ChEMBL ID: CHEMBL1201831
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2008

Molecule: ADALIMUMAB
ChEMBL ID: CHEMBL1201580
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2002

Molecule: ETANERCEPT
ChEMBL ID: CHEMBL1201572
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1998

Molecule: GOLIMUMAB
ChEMBL ID: CHEMBL1201833
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2009

Molecule: LENERCEPT
ChEMBL ID: CHEMBL2108208
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Protein

Molecule: NERELIMOMAB
ChEMBL ID: CHEMBL2108566
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: AFELIMOMAB
ChEMBL ID: CHEMBL2108887
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: ONERCEPT
ChEMBL ID: CHEMBL2107911
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Protein

Molecule: OZORALIZUMAB
ChEMBL ID: CHEMBL1743054
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: PEGSUNERCEPT
ChEMBL ID: CHEMBL1743057
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Protein

Molecule: PLACULUMAB
ChEMBL ID: CHEMBL2108739
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: AZ9773
ChEMBL ID: CHEMBL2109587
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: REMTOLUMAB
ChEMBL ID: CHEMBL4297863
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: ABBV-3373
ChEMBL ID: CHEMBL4297572
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Unknown

Molecule: PATECLIZUMAB
ChEMBL ID: CHEMBL1743056
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: BAMINERCEPT
ChEMBL ID: CHEMBL1742988
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Protein

Molecule: APRATASTAT
ChEMBL ID: CHEMBL206815
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: BAMINERCEPT
ChEMBL ID: CHEMBL1742988
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Protein

Molecule: QUISOVALIMAB
ChEMBL ID: CHEMBL4802198
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: ASUNERCEPT
ChEMBL ID: CHEMBL4297886
Mechanism of Action: BINDING AGENT
Max Phase: 3.0
Molecule Type: Protein

Molecule: VORSETUZUMAB MAFODOTIN
ChEMBL ID: CHEMBL2108672
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody drug conjugate

Molecule: VORSETUZUMAB
ChEMBL ID: CHEMBL2108673
Mechanism of Action: BINDING AGENT
Max Phase: 2.0
Molecule Type: Antibody

Molecule: MDX-1411
ChEMBL ID: CHEMBL2109492
Mechanism of Action: CROSS-LINKING AGENT
Max Phase: 1.0
Molecule Type: Antibody

Molecule: CUSATUZUMAB
ChEMBL ID: CHEMBL4297891
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: ATACICEPT
ChEMBL ID: CHEMBL1742986
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Protein

Molecule: SIBEPRENLIMAB
ChEMBL ID: CHEMBL4594614
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: GSK-1995057
ChEMBL ID: CHEMBL2109590
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Antibody

Molecule: RO-5458640
ChEMBL ID: CHEMBL2109600
Mechanism of Action: INHIBITOR
Max Phase: 1.0
Molecule Type: Antibody

Molecule: BIIB-023
ChEMBL ID: CHEMBL2109598
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: DULANERMIN
ChEMBL ID: CHEMBL2107846
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Protein

Molecule: MAPATUMUMAB
ChEMBL ID: CHEMBL2108621
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Antibody

Molecule: GSK2982772
ChEMBL ID: CHEMBL4071864
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: TIGATUZUMAB
ChEMBL ID: CHEMBL1743080
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Antibody

Molecule: DULANERMIN
ChEMBL ID: CHEMBL2107846
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Protein

Molecule: CONATUMUMAB
ChEMBL ID: CHEMBL1743003
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Antibody

Molecule: DROZITUMAB
ChEMBL ID: CHEMBL1743008
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Antibody

Molecule: APOMAB
ChEMBL ID: CHEMBL2109248
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Antibody

Molecule: LEXATUMUMAB
ChEMBL ID: CHEMBL1743036
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Antibody

Molecule: LBY-135
ChEMBL ID: CHEMBL2109247
Mechanism of Action: AGONIST
Max Phase: 1.0
Molecule Type: Antibody

Molecule: BELIMUMAB
ChEMBL ID: CHEMBL1789843
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2011

Molecule: TABALUMAB
ChEMBL ID: CHEMBL1743075
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: ATACICEPT
ChEMBL ID: CHEMBL1742986
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Protein

Molecule: BLISIBIMOD
ChEMBL ID: CHEMBL2107877
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Protein

Molecule: BRIOBACEPT
ChEMBL ID: CHEMBL2107844
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Protein

Molecule: TIBULIZUMAB
ChEMBL ID: CHEMBL3990000
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: RUPLIZUMAB
ChEMBL ID: CHEMBL2108767
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: TORALIZUMAB
ChEMBL ID: CHEMBL2108747
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: DAPIROLIZUMAB PEGOL
ChEMBL ID: CHEMBL2109478
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: RAVAGALIMAB
ChEMBL ID: CHEMBL4298212
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Antibody

Molecule: TEGOPRUBART
ChEMBL ID: CHEMBL4594460
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: DAZODALIBEP
ChEMBL ID: CHEMBL4594331
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Protein

Molecule: HCBE-11
ChEMBL ID: CHEMBL2109509
Mechanism of Action: AGONIST
Max Phase: 1.0
Molecule Type: Antibody

Molecule: DENOSUMAB
ChEMBL ID: CHEMBL1237023
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2010

Molecule: ZIMLOVISERTIB
ChEMBL ID: CHEMBL4081711
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule
